Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketosteril + Low Protein Diet in Type 2 Diabetic Nephropathy
NCT00363987Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- May 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Ketosteril in diabetic nephropathy (DN) (2 arms), sponsored by Fresenius Kabi. Primary endpoints: Changes in urine protein at 1 year and Changes in Glomerular Filtration Rate at 1 year. Started May 2006; status: completed.
02
Drugs
Ketosteril
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00363987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363987.